Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04452578 · ClinicalTrials.gov registry record · NA
Hepatitis C Virus (HVC) Positive Heart Grafts in HCV Negative Recipients
A NA study of Heart Failure, sponsored by Loma Linda University.
- Completed
- Registry status
- NA
- Development phase
- 2
- Enrollment target
- 1
- Study location
NCT04452578: Completed NA study of Heart Failure, sponsored by Loma Linda University.
NCT04452578 is a NA study of Heart Failure that has completed, run by Loma Linda University. The registered enrollment target is 2 participants, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04452578, a NA study of Heart Failure, has completed, sponsored by Loma Linda University.
- COMPLETED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
- 1
- Study location
Study Summary
To provide proof-of-concept data on the efficacy/safety of transplanting HCV positive donor grafts in HCV negative heart recipients who are currently listed.
Conditions Studied
Interventions
- PROCEDURE Procedure: Heart Transplantation
Study Locations (1)
California
- Loma Linda University Transplant Institute - Loma Linda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2020-06-10 |
| Est. Completion | 2022-06-17 |
| Phase | NA |
What the finished NCT04452578 record still lists
NCT04452578 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 2 participants, a relatively small participant target, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (100% lower).
The record links to 1 condition, with Heart Failure appearing as the primary indexed condition, and to 1 intervention - of which Procedure: Heart Transplantation is the first listed.
NCT04452578 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT04452578 about?
NCT04452578 is a clinical study titled "Hepatitis C Virus (HVC) Positive Heart Grafts in HCV Negative Recipients". To provide proof-of-concept data on the efficacy/safety of transplanting HCV positive donor grafts in HCV negative heart recipients who are currently listed.
What is the current status of trial NCT04452578?
This trial is currently completed. It is a NA study. The enrollment target is 2 participants. The study started on 2020-06-10. Estimated completion is 2022-06-17.
What conditions does trial NCT04452578 study?
This clinical trial studies the following conditions: Heart Failure.
What interventions are being tested in trial NCT04452578?
The interventions under investigation include: Procedure: Heart Transplantation (PROCEDURE).
Who is sponsoring clinical trial NCT04452578?
This trial is sponsored by Loma Linda University, which has 237 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04452578 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04452578's enrollment target sits among peer trials
2 397th of 397 higher than 1 of 397 other Heart Failure trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Heart Failure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Early Feasibility Study of the NORM™ System in Heart Failure Patients (FUTURE-HFII)
RECRUITING · NA
-
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
RECRUITING · NA
-
iCardia4HF: Multi-component mHealth Intervention for Patients With Heart Failure
RECRUITING · NA
-
Optimizing Heart Failure Therapies Among Patients With Limited Access in Denver
RECRUITING · NA
-
Hemodynamic Monitoring to Prevent Adverse Events foLlowing cardiOgenic Shock Trial
RECRUITING · NA
-
Effect of a Quality Improvement Initiative to Address Social Determinants of Health on Rehospitalization Rates in Patients With Heart Failure
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI